Immunocore Holdings Ltd Cash Flow-to-Debt Ratio
Immunocore Holdings Ltd cash flow-to-debt ratio. Immunocore Holdings Ltd (IMCR) has a Cash Flow-to-Debt Ratio of -0.01x as of June 2026, meaning its operating cash flow of $-5.48 Million could theoretically repay 0% of its total liabilities ($699.62 Million) in one year. Check IMCR capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Immunocore Holdings Ltd (2013–2025)
Cash flow-to-debt ratio of Immunocore Holdings Ltd from 2013 to 2025. Historical debt coverage capacity for Immunocore Holdings Ltd across 13 annual periods. Check IMCR cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Immunocore Holdings Ltd Cash Flow-to-Debt Ratio by Year (2013–2025)
Immunocore Holdings Ltd cash flow-to-debt ratio by year from 2013 to 2025. Year-by-year debt coverage analysis for Immunocore Holdings Ltd. For the full cash flow conversion analysis, see IMCR cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.01x | $-7.97 Million | $686.24 Million | ▼ -128.9% |
| 2024 | 0.04x | $26.06 Million | $648.79 Million | ▲ +293.9% |
| 2023 | 0.01x | $2.33 Million | $228.16 Million | ▲ +103.9% |
| 2022 | -0.26x | $-49.21 Million | $187.86 Million | ▲ +67.8% |
| 2021 | -0.81x | $-143.11 Million | $175.76 Million | ▼ -90.7% |
| 2020 | -0.43x | $-60.57 Million | $141.85 Million | ▲ +4.6% |
| 2019 | -0.45x | $-101.38 Million | $226.37 Million | ▼ -274.9% |
| 2018 | -0.12x | $-16.63 Million | $139.19 Million | ▲ +88.3% |
| 2017 | -1.02x | $-61.73 Million | $60.49 Million | ▼ -22.0% |
| 2016 | -0.84x | $-36.90 Million | $44.10 Million | ▼ -175.7% |
| 2015 | -0.30x | $-17.92 Million | $59.04 Million | ▼ -148.0% |
| 2014 | 0.63x | $39.79 Million | $62.98 Million | ▼ -52.7% |
| 2013 | 1.33x | $11.26 Million | $8.44 Million | — |